Spinal Tech

East Providence, RI-based IlluminOss Medical appointed Dirk Kuyper as president and chief executive officer.

InVivo Therapeutics Holdings had its investigational device exemption human trial approved by the FDA for a treatment of spinal cord injuries and neurotrauma conditions.

Stryker Corp. named William Jellison as its chief financial officer.

Biomet Microfixation and Oxford Performance Materials have developed an exclusive distribution agreement for OPM’s OsteoFab Patient Specific Cranial Device.

The Food and Drug Administration issued 13 spine-related device clearances in March.

Here are five thoughts on physician-owned distributorships.

Lewisville, Texas-based Orthofix has appointed Emily Buxton as its new chief financial officer.

Fort Lauderdale, Fla.-based MAKO Surgical received a permanent injunction against Blue Belt Technologies following a lawsuit sparked by Blue Belt hiring a former MAKO sales manager as its vice president of sales.

The FDA approved the start of a clinical trial for Ampio Pharmaceuticals' biologic Ampion to treat knee osteoarthritis, according to Pharma Biz.

Maryland Venture Fund has invested $500,000 in Gaithersburg, Md.-based Cytomedix, a regenerative medicine company currently focused on its AutoloGel System for using platelet-rich plasma to heal wounds, according to Maryland Business News.